Press releases

CHEPLAPHARM continues its expansion course and complements its portfolio with four further products

Right at the beginning of the year, the fast-growing pharmaceutical company CHEPLAPHARM Arzneimittel GmbH secures the product rights for CYMEVENE®,...

Read more / pdf

CHEPLAPHARM engaged DKSH to market its regional business in several Asian countries

Zurich (CH) / Greifswald (DE), December 15, 2017 – In a formal ceremony at the DKSH headquarters in Zurich, DKSH and CHEPLAPHARM Arzneimittel GmbH...

Read more / pdf

CHEPLAPHARM reached the final phase of the Axia Awards

According to the motto “We are creating a future with perspectives”, mid-sized companies were honored for their sustainable and successful management...

Read more / pdf

CHEPLAPHARM plans further investments

On the occasion of the visit of the German Chancellor Angela Merkel and the Minister of Economics Harry Glawe at CHEPLAPHARM in Greifswald, CEO...

Read more / pdf

Mysimba®: Commercialization and distributorship arrangement with Orexigen Therapeutics Ireland, Ltd.

The wholly owned subsidiary of Orexigen Therapeutics, Inc. (OREX), and CHEPLAPHARM Arzneimittel GmbH have executed a distributorship agreement...

Read more / pdf